A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT04194775 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04194775
- Sponsor
- CStone Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2025-06-18
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.